Picture of Pro-Dex logo

PDEX — Pro-Dex Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual income statement for Pro-Dex, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

R2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K8-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalPreliminary
Revenue
Total Revenue4246.153.866.677.5
Cost of Revenue
Gross Profit13.112.714.619.5—
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses36.940.346.755.9—
Operating Profit5.125.767.1710.7—
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes5.699.432.6312.118
Provision for Income Taxes
Net Income After Taxes4.577.072.138.98—
Net Income Before Extraordinary Items
Net Income4.577.072.138.98—
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income4.577.072.138.98—
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS1.221.950.5962.67—